Measurement of regional myocardial blood flow. Application of the electrolytic hydrogen clearance method in man. 1988

M Kawasuji, and F Kawajiri, and T Iwa
Department of Surgery, Kanazawa University School of Medicine, Japan.

To assess myocardial perfusion intraoperatively and to evaluate the adequacy of coronary bypass grafting, we measured regional myocardial blood flow by the electrolytic hydrogen clearance method in 49 patients. Group I comprised 10 patients with nonischemic heart disease and group II, 39 patients with ischemic heart disease undergoing coronary bypass grafting. Group II was subdivided according to the percent stenosis of the coronary arteries supplying the ventricular regions: group IIa, less than 75% stenosis; group IIb, greater than or equal to 75% stenosis. Mean myocardial blood flows were 154 +/- 7, 145 +/- 5, and 98 +/- 9 ml/min/100 gm in groups I, IIa, and IIb, respectively (p less than 0.01, group IIb versus groups I and IIa). Mean blood flows were 161 +/- 19, 159 +/- 12, 78 +/- 12, and 59 +/- 15 ml/min/100 gm in areas of the left anterior descending coronary artery with less than 50%, 75%, 90%, and 99% stenosis in group II. In areas with a totally occluded left anterior descending coronary artery with collaterals, mean flow was 90 +/- 15 ml/min/100 gm. The mean myocardial blood flows were 40 +/- 7 and 100 +/- 14 ml/min/100 gm in areas with anterior Q wave and non-Q wave infarction, respectively (p less than 0.01). After cardiopulmonary bypass, the mean flow increased from 99 +/- 11 to 150 +/- 7 ml/min/100 gm in the grafted areas in group IIb (p less than 0.01), but it did not change in group I or IIa. The electrolytic hydrogen clearance method provided quantitative evaluation of myocardial perfusion and recovery from hypoperfusion by coronary bypass grafting. This method was especially useful in patients undergoing mammary artery grafting.

UI MeSH Term Description Entries
D007430 Intraoperative Care Patient care procedures performed during the operation that are ancillary to the actual surgery. It includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests. Care, Intraoperative
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006859 Hydrogen The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas. Protium,Hydrogen-1
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001026 Coronary Artery Bypass Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion. Aortocoronary Bypass,Bypass, Coronary Artery,Bypass Surgery, Coronary Artery,Coronary Artery Bypass Grafting,Coronary Artery Bypass Surgery,Aortocoronary Bypasses,Artery Bypass, Coronary,Artery Bypasses, Coronary,Bypass, Aortocoronary,Bypasses, Aortocoronary,Bypasses, Coronary Artery,Coronary Artery Bypasses

Related Publications

M Kawasuji, and F Kawajiri, and T Iwa
February 1986, Nihon Jinzo Gakkai shi,
M Kawasuji, and F Kawajiri, and T Iwa
January 1984, Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko,
M Kawasuji, and F Kawajiri, and T Iwa
February 1985, Zhonghua wai ke za zhi [Chinese journal of surgery],
M Kawasuji, and F Kawajiri, and T Iwa
February 1982, Biulleten' eksperimental'noi biologii i meditsiny,
M Kawasuji, and F Kawajiri, and T Iwa
January 1984, American journal of surgery,
M Kawasuji, and F Kawajiri, and T Iwa
July 1986, Kokyu to junkan. Respiration & circulation,
M Kawasuji, and F Kawajiri, and T Iwa
January 1976, International journal of nuclear medicine and biology,
M Kawasuji, and F Kawajiri, and T Iwa
January 1971, The Journal of nuclear biology and medicine,
M Kawasuji, and F Kawajiri, and T Iwa
December 1983, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
Copied contents to your clipboard!